Published Version
Open DOI LinkAbstract
Influenza viruses and severe acute respiratory syndrome coronavirus 2 are respiratory viruses with a high potential for evolution. Their circulation must be carefully monitored.. The development of diagnostic tools, as well as the search for universal vaccines and new treatments, are strategic tools in public health that allow us to be ready to face future emergencies.
Full Text
Open DOI Link
Sign-in/Register to access full text options Topics from this Paper
Severe Acute Respiratory Syndrome Coronavirus- Tools In Public Health
- Strategic Tools
- Respiratory Viruses
- Influenza Viruses + Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes 
Relevant
Not Relevant
The Journal of Molecular Diagnostics
Sep 1, 2022
RelevantNot Relevant SARS‐CoV‐2 evades immune detection in alveolar macrophages RelevantNot Relevant
- EMBO reports
- Oct 28, 2020
RelevantNot Relevant Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?” RelevantNot Relevant
- American Journal of Transplantation
- Jul 1, 2020
RelevantNot Relevant Epidemiologic Changes Caused by the Preventive Measures for the Coronavirus Disease 2019 Pandemic: An Additional Challenge for Pediatricians RelevantNot Relevant
- The Journal of Pediatrics
- Jan 1, 2023
RelevantNot Relevant Eosinophil responses during COVID-19 infections and coronavirus vaccination RelevantNot Relevant
- Journal of Allergy and Clinical Immunology
- Jul 1, 2020
RelevantNot Relevant SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020 RelevantNot Relevant
- Pathology
- Aug 1, 2021
RelevantNot Relevant Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice RelevantNot Relevant
- The American Journal of Pathology
- Jun 1, 2008
RelevantNot Relevant Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges RelevantNot Relevant
- The Innovation
- Sep 1, 2022
RelevantNot Relevant Preventive measures for accompanying caregivers of children in paediatric health care during the COVID-19 pandemic—walking an ethical tightrope RelevantNot Relevant
- Clinical Microbiology and Infection
- May 1, 2021
RelevantNot Relevant Children and SARS-CoV-2 infection: innocent bystanders...until proven otherwise RelevantNot Relevant
- Clinical Microbiology and Infection
- Sep 1, 2020
RelevantNot Relevant Guidance for the management of adult patients with coronavirus disease 2019 RelevantNot Relevant
- Chinese Medical Journal
- Apr 27, 2020
RelevantNot Relevant Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity RelevantNot Relevant
- Clinical Microbiology and Infection
- Mar 1, 2021
RelevantNot Relevant Accelerated COVID-19 vaccine development: milestones, lessons, and prospects RelevantNot Relevant
- Immunity
- Aug 1, 2021
RelevantNot Relevant COVID-19: What do we know? RelevantNot Relevant
- American Journal of Orthodontics and Dentofacial Orthopedics
- Nov 1, 2020
RelevantNot RelevantREAD MORE FROMActualités Pharmaceutiques
Soins oncologiques de support et exercice officinal RelevantNot Relevant
- Actualités Pharmaceutiques
- Nov 1, 2022
RelevantNot Relevant Cadre légal de la livraison du médicament à domicile 
Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Oct 1, 2022
RelevantNot Relevant Vieillissement de la population, dématérialisation, une nouvelle donne pour la pharmacie Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Oct 1, 2022
RelevantNot Relevant Évaluation de la satisfaction des Français à l’égard de la vaccination Covid-19 en officine Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Sep 1, 2022
RelevantNot Relevant L’équipe officinale, nouvel effecteur de la vaccination Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Sep 1, 2022
RelevantNot Relevant Le nirmatrelvir-ritonavir (Paxlovid®), un traitement contre la Covid-19 Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Jun 1, 2022
RelevantNot Relevant Gestion, dispensation et administration des vaccins à l’officine Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Mar 1, 2022
RelevantNot Relevant Le syndrome de l’œil sec, une pathologie en forte progression Open AccessRelevantNot Relevant
Open Access- Actualités Pharmaceutiques
- Feb 1, 2022
RelevantNot Relevant Prise en charge officinale des effets indésirables des chimiothérapies orales RelevantNot Relevant
- Actualités Pharmaceutiques
- Jan 1, 2022
RelevantNot Relevant